2 completed, 1 unknown. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow SOFAR S.p.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX Telelap ALF-X - Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis | Phase 2 | Unknown | Catholic University of the Sacred Heart | 50 | 2015-02-01 | 2015-01-14 |
| Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway. Mesalazine - Colorectal Cancer | Phase 2 | Completed | SOFAR S.p.A. | 21 | 2012-10-01 | 2016-12-02 |
| A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome mesalazine, placebo - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Completed | SOFAR S.p.A. | 20 | 2004-09-01 | 2008-10-16 |
Abdominal Pain (1) · Colorectal Neoplasms (1) · Genital Diseases, Female (1) · Irritable Bowel Syndrome (1) · Neoplasms (1) · Precancerous Conditions (1)
Mesalamine (2)
Italy (3)
Federico Buffoli, Doctor (1) · Giovanni Barbara, MD (1) · Roberto Corinaldesi, MD (1)